US ADHD Therapeutics Market: Long-Acting Treatments Transform Patient Care
The US ADHD therapeutics market is expanding with increasing recognition and diagnosis of ADHD across pediatric and adult populations. Growing awareness of available treatment options, established prescribing practices, and broader access to pharmacological and behavioral interventions are supporting market development. Continued innovation in stimulant and non-stimulant therapies, along with...
0 Comments 0 Shares 71 Views 0 Reviews